Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Cardiovascular Implants Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The cardiovascular implants market has demonstrated strong growth in recent years. It is anticipated to expand from $28.68 billion in 2025 to $30.52 billion in 2026, showing a compound annual growth rate (CAGR) of 6.4%. The expansion observed in the historic period can be linked to the increasing prevalence of cardiovascular diseases, a rise in interventional cardiology procedures, the growth of hospital cardiac care units, the increasing adoption of implantable pacemakers, and the availability of advanced biomaterials.
The cardiovascular implants market is projected to undergo significant growth in the upcoming years, with its size forecast to reach $39.09 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. This expansion over the forecast period is driven by factors such as an expanding aging population, increasing demand for minimally invasive cardiac treatments, the broadening of structural heart disease therapies, a heightened focus on personalized cardiovascular care, and continuous innovation in implant materials and designs. Key trends anticipated during this period include a greater adoption of minimally invasive cardiovascular implants, the rising utilization of drug-eluting and bioabsorbable stents, a growing preference for transcatheter heart valve procedures, the expansion of advanced cardiac rhythm management devices, and an enhanced focus on the long-term durability of implants.
Get A Free Sample Report With In-Depth Market Insights:
Cardiovascular Implants Market Growth Drivers: What’s Behind The Acceleration?
An increasing occurrence of heart conditions is anticipated to fuel the expansion of the cardiovascular implants market. These disorders encompass a range of medical issues impacting the heart and its blood vessels, such as coronary artery disease, heart failure, arrhythmias, and valve disorders. The widespread presence of heart ailments, including coronary artery disease and heart failure, boosts the need for cardiovascular implants like stents and pacemakers for their treatment. Such implants assist the heart and circulatory system in heart failure patients, aid in maintaining a steady heart rhythm, and monitor cardiac activity. For example, a September 2024 report from the British Heart Foundation (BHF) indicated that around 7.6 million people in the UK suffer from heart and circulatory conditions. Projections suggest this number in the UK could grow by 1 million by 2030 and potentially rise by 2 million by 2040, in addition to the present figures. Consequently, the escalating incidence of heart conditions is a key factor propelling the expansion of the cardiovascular implants market.
Cardiovascular Implants Market Segmentation And Category Overview
The cardiovascular implants market covered in this report is segmented –
1) By Product: Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent
2) By Material: Metals and Alloys, Polymers, Biological Materials
3) By Application: Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications
4) By End-Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers
Subsegments:
1) By Coronary Stent: Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents
2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD, Dual-Chamber ICD, Biventricular ICD
3) By Heart Valve: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves
4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker, Dual-Chamber Pacemaker, Biventricular Pacemaker
5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers), CRT-D Devices (Defibrillators)
6) By Peripheral Stent: Carotid Artery Stents, Renal Artery Stents, Femoral Artery Stents
Cardiovascular Implants Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies within the cardiovascular implants market are increasingly concentrating on integrating advanced technology, particularly artificial intelligence (AI), to optimize their market profits and enhance the precision of patient care and treatment. The progress in cardiac monitoring technology entails the continuous observation and recording of a patient’s heart activity, crucial for diagnosing and managing various heart conditions. For example, during June 2023, BIOTRONIK SE & Co. KG, a medical technology firm based in Germany, introduced the inaugural global implantation of its BIOMONITOR IV implantable cardiac monitor (ICM). BIOMONITOR IV stands as a sophisticated ICM, integrating BIOTRONIK’s SmartECG technology with artificial intelligence to decrease false-positive detections by 86% while maintaining the detection of 98% of genuine episodes. Beyond its advanced artificial intelligence capabilities, BIOMONITOR IV offers several other advantages for both patients and healthcare professionals, including extended battery life and wireless connectivity, which facilitate seamless data transmission and remote monitoring, thereby reducing the necessity for frequent in-person clinic appointments.
Cardiovascular Implants Market Industry Leaders And Competitive Landscape
Major companies operating in the cardiovascular implants market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd
View The Full Cardiovascular Implants Market Report:
Cardiovascular Implants Market Regional Analysis And Leading Geography
North America was the largest region in the cardiovascular implants market in 2025. The regions covered in the cardiovascular implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
